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background:  Patients with multi-vessel coronary artery disease (CAD) presenting with STEMI, generally undergo primary PCI, which is 
limited to treating the culprit lesion (CL) rather than complete revascularization (CR). The results from available randomized control trials 
(RCTs) are conflicting. We performed a meta-analysis of all RCTs comparing outcomes in patients undergoing CL vs CR.
methods:  A comprehensive search of SCOPUS from inception till September 2014 was performed using predefined criteria. We compared 
MACE (composite of mortality, reinfarction and revascularization), revascularization, all-cause mortality, and reinfarction.
Results:  Among 5 eligible RCTs, a total of 581 patients underwent CR and 519 patients underwent CL. Patients were followed for a mean 
period of 16.6 months. Rates of MACE and revascularization were lower in patients undergoing CR compared to CL, with risk ratio (RR) 
(95% CI); 0.50 (0.35-0.70) and 0.46 (0.31-0.68) respectively, whereas rates of all-cause mortality and reinfarction showed a trend towards 
decrease RR:0.66 (0.39-1.11) and 0.53 (0.20-1.38) respectively. (Figure)
conclusion:  Results suggest that CR reduces MACE and revascularization rates with a trend towards lower all-cause mortality and 
reinfarction rates. Ongoing RCT, COMPLETE would further help clarify the role of CR. Current guidelines indicating CR as class III 
indication need to be reevaluated and clinical judgement should prevail while treating multivessel CAD patients with STEMI.
 
